Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of United Surgical Partners International Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of United Surgical Partners International Inc since year 2005.
Table 2 shows the detailed insider transactions of United Surgical Partners International Inc since 2005.
The reporting company's ticker symbol is USPI. The reporting company's CIK number is 1101723.
The total value of stock buying since 2005 is $141,300.
The total value of stock sales since 2005 is $13,572,611.
The total value of stock option exercises since 2005 is $4,005,596.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2007-04-13||Wilcox William H (President and CEO)||Option Ex||35,301||13.32||470,209|
|2007-04-12||Kopser Mark A (SVP, Chief Financial Officer)||Option Ex||40,026||12.65||506,448|
|2007-04-12||Wellik John J (SVP, Chief Accounting Officer)||Option Ex||23,885||13.32||318,148|
|2007-04-12||Steen Donald E (Director)||Option Ex||35,301||13.32||470,209|
|2006-09-14||Wellik John J (SVP, Chief Accounting Officer)||Sale||1,471||28.47||41,879|
|2006-08-09||Garrett John C (Director)||Sale||11,000||25.75||283,250|
|2006-06-02||Garrett John C (Director)||Sale||10,000||31.44||314,400|
|2006-05-26||Brodnax Brett (EVP, Development)||Sale||35,000||32.14||1,124,900|
|2006-05-26||Brodnax Brett (EVP, Development)||Option Ex||35,000||15.48||541,800|
|2006-05-22||Garvin Mark C (SVP)||Sale||60,002||31.32||1,879,262|
|2006-05-22||Garvin Mark C (SVP)||Option Ex||60,002||14.99||899,188|
|2006-05-16||Garvin Mark C (SVP)||Sale||8,341||31.00||258,571|
|2006-05-05||Garvin Mark C (SVP & Chief Operating Officer)||Sale||7,800||32.65||254,670|
|2006-03-14||Wellik John J (SVP, Chief Accounting Officer)||Sale||2,895||35.21||101,932|
|2006-03-10||Wilcox William H (President and CEO)||Sale||30,000||35.20||1,055,850|
|2006-02-28||Steen Donald E (Director)||Sale||50,000||35.03||1,751,500|
|2006-02-28||Steen Donald E (Director)||Option Ex||50,000||7.00||350,000|
|2005-11-18||Garrett John C (Director)||Sale||10,640||38.12||405,596|
|2005-11-17||Wellik John J (SVP, Chief Accountin)||Sale||4,500||38.79||174,555|
|2005-11-03||Steen Donald E (Director)||Sale||50,000||35.63||1,781,350|
|2005-09-12||Kopser Mark A (SVP, Chief Financial)||Sale||15,000||39.37||590,550|
|2005-08-10||Newman James Ken (CEO)||Buy||3,750||37.68||141,300|
|2005-06-13||Garvin Mark C (Chief Operating Officer)||Sale||1,183||51.75||61,220|
|2005-05-12||Wilcox William H (President and CEO)||Sale||30,000||46.27||1,388,040|
|2005-05-10||Wellik John J (SVP, Chief Accountin)||Sale||4,000||46.80||187,180|
|2005-03-10||Brodnax Brett (EVP, Development)||Sale||10,000||40.97||409,700|
|2003-11-12||Quaelly Paul B (Director)||Sale||17,500||32.49||568,575|
Insider trading activities including stock purchases, stock sales, and option exercises of USPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of United Surgical Partners International Inc (symbol USPI, CIK number 1101723) see the Securities and Exchange Commission (SEC) website.